The Impact of National Pharmaceutical Centralized Purchase and Continuation Policies on Drug Usage,Prices and Costs
- VernacularTitle:国家药品集中带量采购及接续政策对药品用量、价格及费用的影响研究
- Author:
Haoyang WANG
1
;
Yue HAN
;
Jinping XIE
;
Rong SHAO
Author Information
1. 中国药科大学监管科学研究院 江苏 南京 211198
- Keywords:
pharmaceutical centralized purchase;
purchasing policy;
drug price and cost;
generic drugs;
originator drug
- From:
Chinese Health Economics
2024;43(10):31-37
- CountryChina
- Language:Chinese
-
Abstract:
Objective:It aims to evaluate the impact of National Pharmaceutical Centralized Purchase(NPCP)and continuation policies on drug utilization,pricing,and expenditure,providing insights for optimizing national procurement strategies.Methods:Using descriptive statistics,a statistical analysis was conducted to examine changes in drug procurement amounts,Defined Daily Doses(DDDs),Defined Daily Dose cost(DDDc),and generic drug substitution rates pre-and post-implementation of the NPCP and continuation policies in hospitals and pharmacies across four municipalities.Results:The policy successfully achieved its goals of streamlining procurement processes,reducing drug prices,and promoting generic drug substitution.However,a notable trend of originator drug diversion to the retail sector was observed,indicating lingering patient reservations towards generics.Conclusion:It is needed to clarty the relation ship between NPCP continous policy and the medical insurance payment standard decision,strengthen the real-world evaluation on selected drug efficacy and safety,enhance the publicity on rated generic drugs,and promote the acceptance of public awareness.
